blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3498337

EP3498337 - COMPOSITION FOR THE RELIEF, IMPROVEMENT, PREVENTION AND/OR TREATMENT OF DRY EYE SYNDROME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.03.2021
Database last updated on 07.10.2024
FormerExamination is in progress
Status updated on  26.06.2020
FormerRequest for examination was made
Status updated on  27.12.2019
FormerThe application has been published
Status updated on  17.05.2019
Most recent event   Tooltip05.03.2021Application deemed to be withdrawnpublished on 07.04.2021  [2021/14]
Applicant(s)For all designated states
Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir
Avda. Blas Infante s/n
23740 Andújar (Jaén) / ES
[2019/25]
Inventor(s)01 / Villegas Becerril, Enrique
Avda. Blas Infante, s/n Andújar
23740 Jaén / ES
 [2019/25]
Representative(s)Hoffmann Eitle
Hoffmann Eitle S.L.U.
Paseo de la Castellana 140, 3a planta
Edificio LIMA
28046 Madrid / ES
[2019/25]
Application number, filing date19155489.823.09.2015
[2019/25]
Priority number, dateES2014003137923.09.2014         Original published format: ES 201431379
ES2014003185416.12.2014         Original published format: ES 201431854
[2019/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3498337
Date:19.06.2019
Language:EN
[2019/25]
Search report(s)(Supplementary) European search report - dispatched on:EP22.05.2019
ClassificationIPC:A61P27/04, A61K36/886, A61K9/00, A61K9/127, A61K31/65, A61K36/28, A61K36/53
[2019/25]
CPC:
A61K36/53 (EP,US); A61K31/65 (EP,US); A61K36/28 (EP,US);
A61K36/886 (EP,US); A61K9/0048 (US); A61K9/127 (EP,US);
A61P27/04 (EP,US) (-)
C-Set:
A61K36/28, A61K2300/00 (US,EP);
A61K36/53, A61K2300/00 (US,EP);
A61K36/886, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/05]
Former [2019/25]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZUSAMMENSETZUNG ZUR LINDERUNG, BESSERUNG, PRÄVENTION UND/ODER BEHANDLUNG VON TROCKENEM AUGE[2019/25]
English:COMPOSITION FOR THE RELIEF, IMPROVEMENT, PREVENTION AND/OR TREATMENT OF DRY EYE SYNDROME[2019/25]
French:COMPOSITION DE SOULAGEMENT, D'AMÉLIORATION, DE PRÉVENTION ET/OU DE TRAITEMENT DU SYNDROME DE L' IL SEC[2019/25]
Examination procedure19.12.2019Amendment by applicant (claims and/or description)
19.12.2019Examination requested  [2020/05]
19.12.2019Date on which the examining division has become responsible
01.07.2020Despatch of a communication from the examining division (Time limit: M04)
12.11.2020Application deemed to be withdrawn, date of legal effect  [2021/14]
02.12.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/14]
Parent application(s)   TooltipEP15845327.4  / EP3199163
Fees paidRenewal fee
05.02.2019Renewal fee patent year 03
05.02.2019Renewal fee patent year 04
23.09.2019Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.09.202006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US6013259  (DE DE LA PENA NURIA E A C [US], et al) [Y] 1-15 * claims 1-4 *;
 [XY]WO2013140009  (GARCIA GILABERT JUAN MIGUEL [ES]) [X] 1-5,8-11,13 * claims 1-4 * [Y] 1-15;
 [Y]  - INOOKA M, "Aqueous external composition for use as eye drops or nasal drops, comprises alginic acid, nonionic surfactant, boric acid and phosphoric acid, tocopherol and azulene or its derivatives", WPI/THOMSON,, (20060831), vol. 2006, no. 56, XP002484689 [Y] 1-15 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.